Translational Lecture 01

Hugo Prazeres, i3S, Portugal

Hugo graduated in Biology from the Faculty of Science and Technology of the University of Coimbra (FCTUC), where he also completed a Masters degree in Molecular and Cell Biology, and then obtained his doctoral degree in Biomedicine from the Faculty of Medicine of the University of Porto. Hugo has published several peer-reviewed scientific papers and has lectured courses in doctoral programs, as well as the Oncobiology Discipline at FCTUC. In 2007 Hugo co-founded a Biotech company headquartered at the Pedro Nunes Institute, in Coimbra. Besides the experience in management accumulated in this setting, Hugo has developed skills in the field of industrial property, including courses by Portugals INPI on patent preparation, database consultation and writing of patent claims. Hugo also took an MBA and has acted as a consultant in subjects such as CE marking and Manufacture of and In Vitro Diagnostics (IVD) Medical Devices. Hugo has been awarded several prizes including the Young Investigator Award of the European Society of Human Genetics and the BES Inovation Award. More recently Hugo has been devoted to technology transfer and enterpreneurship, IP management, licensing and assistance to spin-offs.


Translational Lecture 02

Warrick Harniess, Scandinavia Stories | UCL, UK

Warrick founded Scandinavia Stories Ltd, a learning and development consultancy that specialises in communications, entrepreneurship and innovation. Clients include UK and international universities, fast-growing SMEs, professional services firms and blue chip companies. He learned his craft during a ten-year career at Pearson Education, and as a lifelong musician inspired by punk rock and the do-it-yourself ethos. Currently he is working on a book, Red, White and Radical: What Organisations Can Learn About Change from the Rise of American Conservatism, that will be published by Routledge in early 2020.



Translational Lecture 03

Eckhard Schwenner, Health-I Business Consulting, Germany

Graduation and PhD in Organic Chemistry. Has over 30 years international management and business experience within the Healthcare industry. Strong track record in multidisciplinary program management, Research and Development and Business management functions in Corporate Research as well as Pharmaceuticals and Diagnostics Business Groups in Bayer AG, Siemens and Philips. Has developed and implemented corporate wide strategies as head of Bayer`s global R&D coordination function. Start up and deal making experience as CEO of pes diagnosesysteme, an immunoassay based Point of Care company. Business Management experience as VP at Bayer Diagnostics USA and as CEO Emerging Markets, Healthcare Incubator, at Philips Eindhoven. Lived and worked in Germany, the USA, Japan and Netherlands, with recent working experience in the growth markets China and India. Currently lives and works in Germany as CEO of Health-I Business Consulting. Health-I is consulting start up Businesses in the Healthcare/Lifesciences industry and providing Interim Management as for enverdis GmbH an innovative medical device company in Germany.